The State JSC \u201cPrivatisation Agency\u201d is organizing a webinar scheduled on 2 November 2016 at 16:00(EEST). Please note that attendees have to register for the webinar in advance \u2013 detailed information on the registration process is provided below.<\/p>\n\n\n\n
The webinar will be hosted by Mr. Vladimirs Loginovs, the Chairman of the Executive Board of the State JSC \u201cPrivatisation Agency\u201d. The presentation will be held in English.<\/p>\n\n\n\n
During the webinar Mr. Loginovs will provide information on the auctions of the state-owned shares of JSC \u201cGrindeks\u201d to be held on 8 November<\/strong> (click here<\/a> for more details). Registration process<\/strong> What is a corporate webinar?<\/strong> About JSC \u201cGrindeks\u201d<\/strong> About the State JSC \u201cPrivatisation Agency\u201d<\/strong> The State JSC \u201cPrivatisation Agency\u201d is organizing a webinar scheduled on 2 November 2016 at 16:00(EEST). Please note that attendees have to register for the…<\/p>\n","protected":false},"author":3,"featured_media":1756,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1755","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"acf":[],"_links":{"self":[{"href":"https:\/\/grindeks.com\/en\/wp-json\/wp\/v2\/posts\/1755","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/grindeks.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/grindeks.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/grindeks.com\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/grindeks.com\/en\/wp-json\/wp\/v2\/comments?post=1755"}],"version-history":[{"count":0,"href":"https:\/\/grindeks.com\/en\/wp-json\/wp\/v2\/posts\/1755\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/grindeks.com\/en\/wp-json\/wp\/v2\/media\/1756"}],"wp:attachment":[{"href":"https:\/\/grindeks.com\/en\/wp-json\/wp\/v2\/media?parent=1755"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/grindeks.com\/en\/wp-json\/wp\/v2\/categories?post=1755"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/grindeks.com\/en\/wp-json\/wp\/v2\/tags?post=1755"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
After the presentation webinar participants are welcome to ask questions. Due to the limited webinar time, please send in your questions in advance till 1 November 2016<\/strong> to e-mail: ieva.unda@nasdaq.com<\/a>.<\/p>\n\n\n\n
To follow the webinar, you will need a computer with an internet connection and headphones. To join the webinar, you need to register in advance via http:\/\/ej.uz\/1ij8<\/a>. You will be provided with the webinar link and instructions to join webinar successfully. When joining the webinar for the first time, you will be asked to download the system application on your computer which will take only a few seconds.<\/p>\n\n\n\n
A corporate webinar is a virtual conference, during which a company\u2019s representative provides information about the company, its activities and future plans. A webinar provides an opportunity to receive information directly from the company while being located anywhere, as well as to receive answers to questions of interest to you.
For more information on webinar service please visit: http:\/\/www.nasdaqbaltic.com\/en\/products-services\/webinars-3\/<\/a>.<\/p>\n\n\n\n
JSC \u201cGrindeks\u201d is an international, vertically integrated pharmaceutical company in the Baltics. Its business is focused on research, development, manufacturing and sale of original products, generics and active pharmaceutical ingredients. JSC \u201cGrindeks\u201d specialises in the heart and cardiovascular, CNS and anti-cancer medication therapeutic groups. The range of goods includes the original products Mildron\u0101ts\u00ae and Ftorafur\u00ae and more than 100 forms of generic drugs. The Group of JSC \u201cGrindeks\u201d consists of five subsidiary companies in Latvia, Estonia, Slovakia and Russia, as well as representative offices in 13 countries. Products of the company are exported to 70 countries and its export comprises 90% of the total turnover. The key markets include the EU countries, Russia and other CIS countries, the U.S.A., Canada, Japan and Vietnam.
As per results of TOP 101 of Latvia\u2019s Most Valuable Enterprises<\/em>, in year 2016 the JSC \u201cGrindeks\u201d was acknowledged as No.28 among the most valuable Latvia\u2019s enterprises and No.2 most valuable within the industry \u201cManufacturing: consumer goods\u201d.2<\/sup><\/p>\n\n\n\n
The State JSC \u201cPrivatisation Agency\u201d ensures the governance, privatisation and alienation of the state-owned shares. Within the framework of implementing the SOE governance reform, the state participation in enterprises wherein the state has no strategic interest is being gradually decreased. During the 1st<\/sup> half of 2016 the State JSC \u201cPrivatisation Agency\u201d held state owned shares in 39 capital companies, incl. in stock market listed companies JSC \u201cValmieras stikla \u0161\u0137iedra\u201d, JSC \u201cGrindeks\u201d and JSC \u201cLatvian Shipping\u201d.<\/p>\n","protected":false},"excerpt":{"rendered":"